The board of directors of Smoltek has decided on an offset issue to Qamcom

On Dec. 16, 2025 Smoltek’s board approved a directed share issue of 727,783 shares to Qamcom to settle consultancy claims arising Dec. 1, 2024–Nov. 30, 2025 under their 2023 cooperation agreement, at a VWAP‑based subscription price of SEK 0.4212024738 per share; the issue increases outstanding shares to 180,799,125 (≈0.4% dilution) and raises share capital by SEK 86,699.52. The equity‑for‑debt swap preserves Smoltek cash while keeping access to Qamcom technical resources critical to its semiconductor and green hydrogen development, and the board says the terms are market‑based and justified as fulfillment of contractual obligations. Investors should view the move as modest dilution that signals continued reliance on external R&D partners and active cash management rather than a capital raise through the market.

Analysis

On Dec 16, 2025 Smoltek's Board resolved a directed new share issue of 727,783 shares to Qamcom to set off Qamcom's claims arising December 1, 2024–November 30, 2025 under the March 9, 2023 cooperation agreement. The subscription price is SEK 0.421202473814310 per share, calculated by summing month-by-month VWAP-based prices; outstanding shares rise from 180,071,342 to 180,799,125 (≈0.4% dilution) and share capital increases by SEK 86,699.51695626470.

Smoltek states the issuance settles consultant-cost liabilities and preserves cash while maintaining access to Qamcom technical consultants for its semiconductor and hydrogen development activities, and the Board describes the terms as market-based and necessary to fulfil contractual obligations. The press release emphasizes this is a directed non-public settlement (not a prospectus offering) and reiterates forward-looking statement caveats and legal distribution restrictions.

The dilution is small in percentage terms but the transaction highlights continued reliance on external R&D partners and an equity-for-debt settlement approach that could recur if cash payments lag consultant costs. Attached data show mildly negative sentiment (sentiment_score −0.25) and a modest market_impact_score (0.12), suggesting limited immediate market disruption but warranting monitoring of future offset issues, liquidity disclosures and delivery of technical or commercial milestones as catalysts or risks.

Key Decisions for Investors

• Monitor Smoltek's upcoming quarterly liquidity disclosures and any further directed issues, as the SEK 0.4212-per-share offset preserves cash but may indicate funding reliance on equity-for-debt settlements
• Require observable technical or commercial milestones from the Qamcom collaboration in semiconductors or hydrogen before increasing exposure, since Smoltek remains development-stage and the Board used directed issuance to meet contractual obligations
• Maintain position sizing or consider hedging for downside risk given the mildly negative sentiment and potential for future dilution, while treating this single 0.4% dilution as modest rather than immediately material